Overexpression of eIF5A‐2 is an adverse prognostic marker of survival in stage I non–small cell lung cancer patients
暂无分享,去创建一个
X. Bian | Mengzhong Liu | Y. Zeng | D. Xie | X. Guan | Hong Zhao | Binkui Li | Yan-Hui Liu | Li-ru He
暂无分享,去创建一个
X. Bian | Mengzhong Liu | Y. Zeng | D. Xie | X. Guan | Hong Zhao | Binkui Li | Yan-Hui Liu | Li-ru He